Intensified competition between domestic and foreign enterprises, speeding up the localization of pharmaceutical machinery is imminent

[ Chemical Machinery Equipment Network Market Analysis ] Recently, some people in the industry have publicly stated that China’s scientific research volume has firmly occupied the forefront of the world, and the number of papers has been ranked *2 for 4 consecutive years.
*The number of papers ranked first in the world in 2020, but the research results produced are not The R&D and manufacturing of real equipment is very disproportionate.
At present, domestic instruments and equipment are still mainly imported.
Among the top 20 instrument companies in the world, none of them are Chinese companies.
For various reasons, the gap between my country and developed countries in the research and development and manufacturing of * instruments is increasing.

*Coincidentally, as far as the development status of my country's pharmaceutical equipment industry is concerned, it also has many drawbacks such as the lack of core technology and the lack of market competitiveness of domestic equipment compared with foreign equipment.
It is understood that the current domestic pharmaceutical equipment industry has basically been able to meet the needs of the domestic market, while the scale of overseas markets is also expanding, with an average annual growth rate of export delivery value exceeding 20%.
However, according to the "In-depth Market Research and Investment Strategy Recommendation Report for the Pharmaceutical Equipment Industry 2020-2024", although domestic pharmaceutical equipment has basically achieved import substitution in the middle and low-end markets , it is basically still available in the * market, such as centrifuges and other products.
The market is monopolized by imported brands.

 

The industry believes that the main reason for this phenomenon is due to the fact that domestic pharmaceutical equipment companies are basically small and medium-sized, their independent innovation capabilities are not strong, and they lack enthusiasm in R&D investment.
This makes the product technology of domestic equipment and Quality cannot be highlighted in the *market competitive advantage.

 

　　In addition, the current domestic pharmaceutical equipment companies are also facing competitive pressure from foreign pharmaceutical equipment giants.
It is reported that the huge dividends in the Chinese market are attracting more and more companies to invest.
The foreign-funded pharmaceutical equipment giants have increased their sales and investment in the Chinese market, and rely on their own advantages in R&D, equipment, technology, capital, and talents to occupy a relatively high share of the domestic * pharmaceutical equipment market.
Under the background, domestic domestic related enterprises have also ushered in more fierce competition.

 

　　So how should the domestic pharmaceutical equipment industry accelerate the localization of pharmaceutical equipment and expand its market share in the pharmaceutical field? In this regard, industry insiders pointed out that domestic pharmaceutical equipment companies should make efforts in three aspects: breaking through core technology bottlenecks, improving R&D and design capabilities, and grasping the industry's major trends.

 

　　It is understood that continuous consolidation of internal strength, improvement of innovative research and development capabilities, and creation of independent technology for pharmaceutical equipment are an important way to realize domestic pharmaceutical equipment from the low-end to the * market.
In fact, in recent years, domestic pharmaceutical equipment companies have been continuously exploring the areas of independent innovation and deep cultivation.
For example, the pharmaceutical equipment industrialization project created by Xinma Pharmaceutical will form a complete industrial chain of solid preparations-laboratories, customized, production-type, and closed-type production lines after completion.

 

　　At present, in the context of the diversification of the needs of pharmaceutical companies and the rising costs each year, innovative research and development of overall solutions has gradually become an important development direction for domestic pharmaceutical equipment companies.
For example, Canaan Technology has clearly stated that the company can provide pharmaceutical companies with specialized, customized, integrated, and intelligent solid preparation smart factory complete line equipment and supporting process design solutions, and have process design capabilities and core equipment.
R&D and manufacturing capabilities.
In the future, it will continue to deepen its strategic layout, strive to become a solution provider for the entire line of pharmaceutical equipment smart factories, and continue to advance into the big health industry.

 

　　In general, the pharmaceutical equipment industry is currently in a golden period of development, and domestic and foreign equipment companies are expected to usher in huge development opportunities.
However, in the context of a series of medical reform policies that continue to force the domestic pharmaceutical industry to innovate and upgrade, and foreign companies continue to seize the domestic market with technology, the domestic pharmaceutical equipment industry needs to keep pace with the times and accelerate the localization of pharmaceutical equipment through innovation.
And make efforts to the * market.
In addition, through the development of differentiated services, the production level and brand image can be improved from inside to outside to achieve better development.

 

　　Original title: Intensified competition between domestic and foreign pharmaceutical machinery companies, speeding up the localization of * pharmaceutical machinery is imminent